Free Trial

Itron, Inc. $ITRI Shares Purchased by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC

Itron logo with Computer and Technology background

Key Points

  • UBS Asset Management significantly increased its stake in Itron, Inc. by 129.7% during Q1, now holding approximately 732,274 shares valued at $76.71 million.
  • A variety of institutional investors, including Invesco and Amundi, also raised their stakes in Itron, with institutional ownership reaching 96.19% of the company's stock.
  • Despite reporting earnings per share of $1.62 for the last quarter, exceeding estimates, Itron's revenue slightly declined by 0.4% year-over-year, reflecting a challenging market environment.
  • Interested in Itron? Here are five stocks we like better.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Itron, Inc. (NASDAQ:ITRI - Free Report) by 129.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 732,274 shares of the scientific and technical instruments company's stock after purchasing an additional 413,487 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned about 1.61% of Itron worth $76,713,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of ITRI. Wellington Management Group LLP increased its stake in Itron by 180.7% in the 4th quarter. Wellington Management Group LLP now owns 333,363 shares of the scientific and technical instruments company's stock valued at $36,197,000 after purchasing an additional 214,600 shares in the last quarter. Amundi increased its stake in Itron by 18.4% in the 1st quarter. Amundi now owns 929,407 shares of the scientific and technical instruments company's stock valued at $97,313,000 after purchasing an additional 144,361 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Itron in the 4th quarter valued at approximately $14,563,000. GAMMA Investing LLC grew its holdings in Itron by 10,278.1% during the 1st quarter. GAMMA Investing LLC now owns 122,150 shares of the scientific and technical instruments company's stock valued at $12,796,000 after buying an additional 120,973 shares during the last quarter. Finally, Nuveen Asset Management LLC grew its holdings in Itron by 21.5% during the 4th quarter. Nuveen Asset Management LLC now owns 560,478 shares of the scientific and technical instruments company's stock valued at $60,857,000 after buying an additional 99,142 shares during the last quarter. 96.19% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Itron

In related news, SVP Justin K. Patrick sold 388 shares of Itron stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $48,620.28. Following the transaction, the senior vice president owned 20,761 shares in the company, valued at approximately $2,601,560.91. This trade represents a 1.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Joan S. Hooper sold 970 shares of Itron stock in a transaction on Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $121,550.70. Following the completion of the transaction, the chief financial officer owned 88,394 shares in the company, valued at $11,076,652.14. The trade was a 1.09% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 3,037 shares of company stock valued at $380,566 in the last ninety days. Company insiders own 1.51% of the company's stock.

Wall Street Analysts Forecast Growth

ITRI has been the topic of a number of analyst reports. Wall Street Zen upgraded Itron from a "hold" rating to a "buy" rating in a report on Saturday, August 2nd. Roth Capital increased their target price on Itron from $130.00 to $150.00 and gave the company a "buy" rating in a report on Tuesday, July 22nd. Guggenheim reiterated a "buy" rating and set a $155.00 target price (up previously from $133.00) on shares of Itron in a report on Monday, July 14th. Johnson Rice cut Itron from a "buy" rating to an "accumulate" rating in a report on Friday, August 1st. Finally, JPMorgan Chase & Co. upgraded Itron from a "neutral" rating to an "overweight" rating and increased their target price for the company from $128.00 to $145.00 in a report on Thursday, July 31st. Ten research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $136.55.

View Our Latest Stock Analysis on ITRI

Itron Trading Up 0.5%

Shares of ITRI stock traded up $0.63 during mid-day trading on Monday, hitting $120.17. 430,032 shares of the company's stock were exchanged, compared to its average volume of 586,423. Itron, Inc. has a fifty-two week low of $90.11 and a fifty-two week high of $140.04. The stock has a 50-day simple moving average of $127.60 and a two-hundred day simple moving average of $117.63. The company has a quick ratio of 1.75, a current ratio of 2.04 and a debt-to-equity ratio of 0.48. The stock has a market cap of $5.49 billion, a price-to-earnings ratio of 20.54, a PEG ratio of 0.66 and a beta of 1.46.

Itron (NASDAQ:ITRI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.29. Itron had a return on equity of 19.69% and a net margin of 11.05%.The business had revenue of $606.76 million for the quarter, compared to analysts' expectations of $610.36 million. During the same quarter last year, the firm earned $1.21 earnings per share. The business's revenue was down .4% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. Equities analysts expect that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Itron Profile

(Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Featured Articles

Institutional Ownership by Quarter for Itron (NASDAQ:ITRI)

Should You Invest $1,000 in Itron Right Now?

Before you consider Itron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.

While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.